✦ LIBER ✦

Phase I clinical trial of alternating belotecan and oral etoposide in patients with platinum-resistant or heavily treated ovarian cancer

✍ Scribed by Y. Lee; J. Hwang; H. Yoo; M. Lim; S. Seo; S. Park; S. Kang

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II Study of Oral Etoposide and Int

✍ Matsumoto, K.; Katsumata, N.; Saito, I.; Shibata, T.; Konishi, I.; Fukuda, H.; K 📂 Article 📅 2012 🏛 Oxford University Press 🌐 English ⚖ 74 KB

Second-Line Treatment with Intravenous G

✍ Bruzzone, M.; Centurioni, M.G.; Giglione, P.; Gualco, M.; Merlo, D.F.; Miglietta 📂 Article 📅 2011 🏛 S. Karger AG 🌐 English ⚖ 469 KB

Phase I trial of the proteasome inhibito

✍ Pedro T. Ramirez; Charles N. Landen Jr.; Robert L. Coleman; Michael R. Milam; Ch 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 125 KB

The PACOVAR-trial: A phase I/II study of

✍ Michael Eichbaum; Christine Mayer; Regina Eickhoff; Esther Bischofs; Gerhard Geb 📂 Article 📅 2011 🏛 BioMed Central 🌐 English ⚖ 191 KB

A Phase II trial of oral capecitabine in

✍ Judith K. Wolf; Diane C. Bodurka; Claire Verschraegen; Charlotte C. Sun; Donna B 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 167 KB

Mutation and Protein Expression Biomarke

✍ H. Gunqor; E. Stronach; E. Curry; A. Saleem; R. Agarwal; S. Blagden; S. Babar; G 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 62 KB